Tech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Control Bionics.
RELATED STOCKHEAD STORIES
Stockhead TV
Road to 2025: Control Bionics’ breakout into sports science
Health & Biotech
Health Check: Clinical trials don’t sleigh down for the silly season
Health & Biotech
Strong growth boosts Control Bionics’ US revenue in H1 FY25
Health & Biotech
Control Bionics leaps into new US and Japanese markets with strategic deals
Health & Biotech
Biocurious: Armed with a lucky payment number, Control Bionics plots its US expansion
News
Closing Bell: Arcadium holders cash in, Oil rallies as Milton hits, and GYG keeps momentum going
Health & Biotech
Health Check: Control Bionics eyes 20pc revenue growth and ‘near term’ profitability
News
Closing Bell: Energy stocks cushion ASX’s mini crash; Infinity soars on Cangai copper acquisition
Health & Biotech
Control Bionics boosts revenue with faster NDIS approvals and new leasing program
News
ASX Small Caps Lunch Wrap: Geopolitical turmoil still suppressing markets… buy the dip?
News
Market Highlights: Oil stocks could rally again on Biden’s comments; and 5 other ASX small caps to watch
Health & Biotech
Control Bionics inks UK and Ireland distribution deal for NeuroNode
News
Closing Bell: ASX tracks global selloff; Yancoal and GYG amongst new ASX200 entrants
Health & Biotech
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’
Health & Biotech
Digital prescription: ASX stocks transforming healthcare sector
Stockhead TV
Long Shortz with Control Bionics: Major MedTech milestone with new US recognition
Health & Biotech